Work

Clinical outcomes of lutetium-177-vipivotide tetraxetan in men with metastatic castration-resistant prostate cancer at a single academic center.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.84

Authors: Adam Khorasanchi, Jinesh S. Gheeya, Timothy D. Gauntner, Menglin Xu, Elshad Hasanov, Katharine A. Collier, Lingbin Meng, Danielle Elise Zimmerman, Peng Wang, Edmund Folefac, Paul Monk, Amir Mortazavi, Steven K. Clinton, Yuanquan Yang

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Pelotonia, The Ohio State University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407701711

Cites:

Cited by:

Related to: 10